Canada markets close in 6 hours 23 minutes

Adamis Pharmaceuticals Corporation (ADMP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.3275-0.0125 (-3.68%)
As of 09:36AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.3400
Open0.3375
Bid0.3375 x 800
Ask0.3500 x 2200
Day's Range0.3202 - 0.3351
52 Week Range0.3100 - 1.4800
Volume125,343
Avg. Volume632,132
Market Cap49.119M
Beta (5Y Monthly)1.00
PE Ratio (TTM)N/A
EPS (TTM)-0.2730
Earnings DateAug 10, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.42
  • GlobeNewswire

    Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders

    Meeting adjourned only with respect to reverse stock split proposal until September 8, 2022SAN DIEGO, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that its 2022 Annual Meeting of Stockholders (“Annual Meeting”) was convened, as scheduled. At the Annual Meeting, all items of business were considered, with the exception of Proposal 2, the proposal to adopt and approve a proposed amendment to the company’s restated certificate of incorporation

  • GlobeNewswire

    Adamis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

    Management to host webcast/conference call today at 1:30 p.m. PT / 4:30 p.m. ETSAN DIEGO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease, today reported financial results for the second quarter of 2022 and provided an update on recent corporate developm

  • GlobeNewswire

    Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update

    SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announced that it will host an investor conference call on Wednesday, August 10, 2022 at 1:30 p.m. Pacific Time to discuss its financial and operating results for the second quarter 2022 as well as provide a corporate update. The company’s press releas